Medtronic
$86.44Change from previous close: +0.17%Absolute change: +$0.15
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $110.57B
- Enterprise value
- $130.52B
- P/E (trailing 12 months)
- 21.2
- Forward P/E
- 13.5
- PEG
- 1.55
- Price/book
- 2.20
- Price/sales
- 2.95
- EV/EBITDA
- 12.5
- EV/revenue
- 3.48
Profitability and growth
- Gross margin
- 65.3%
- Operating margin
- 19.3%
- Net margin
- 13.9%
- ROE
- 10.6%
- ROA
- 5.1%
- Revenue growth (year over year)
- 13.7%
- Earnings growth (year over year)
- 40.7%
Financial health
- Total cash
- $8.82B
- Total debt
- $28.15B
- Debt/equity
- 0.55
- Current ratio
- 2.07
- Quick ratio
- 1.29
Dividends
- Annual dividend per share
- $2.88
- Dividend yield
- 3.3%
- Payout ratio
- 70.2%
- Ex-dividend date
- September 25, 2026
Analysts and estimates
- Average price target
- $104.83
- Median price target
- $106.00
- High price target
- $121.00
- Low price target
- $85.00
- Analysts with a price target
- 24
- Consensus
- Buy
- Forward EPS
- $6.41
- EPS estimate, current year
- $5.97
Shares and trading
- Beta
- 0.57
- Average volume
- 8.8M
- Shares outstanding
- 1.28B
- Float
- 1.28B
- Institutional ownership
- 88.6%
- Insider ownership
- 0.3%
- Short interest (% of float)
- 1.4%
- Short ratio (days)
- 2.17